Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion

Research output: Contribution to journalArticle

10 Citations (Scopus)
Original languageEnglish
Pages (from-to)1696-1702
JournalTransfusion
Volume52
DOIs
Publication statusPublished - 2012

Cite this